NewsRamp is a PR & Newswire Technology platform that enhances press release distribution by adapting content to align with how and where audiences consume information. Recognizing that most internet activity occurs outside of search, NewsRamp improves content discovery by programmatically curating press releases into multiple unique formats—news articles, blog posts, persona-based TLDRs, videos, audio, and Zero-Click content—and distributing this content through a network of news sites, blogs, forums, podcasts, video platforms, newsletters, and social media.
FAQ: Softgel Source's Rapid Custom Softgel Prototyping Program in Portland, Oregon
TL;DR
Softgel Source's 2026 program offers U.S. companies production priority and no minimum orders to rapidly test softgels, creating a competitive edge in domestic manufacturing.
The program enables rapid turnaround of custom softgels through priority production and no MOQ, facilitating efficient product testing and reformulation for regulatory compliance.
This initiative supports U.S. manufacturing growth and job creation while helping companies adapt to regulations, strengthening domestic supply chains for essential products.
Softgel Source's boutique manufacturing in Portland helps biotech and pharmaceutical companies quickly test new formulations with fast turnaround and no minimum order requirements.
Found this article helpful?
Share it with your network and spread the knowledge!
Softgel Source has established a rapid custom softgel prototyping program that offers production priority and no minimum order quantity (MOQ) to facilitate fast turnaround of softgel product orders for testing purposes.
Softgel Source is headquartered in Portland, Oregon, USA, in the Pacific Northwest region.
The program targets U.S. biotech and pharmaceutical businesses, as well as companies in vitamin, medication, supplement, and pet product industries that need to rapidly develop and test new softgel products and formulations.
The program helps U.S. companies bring manufacturing back home, creating a stronger competitive edge by enabling rapid domestic product development and testing while avoiding offshore supply chain disruptions, long lead times, and shifting tariffs.
The program's fast turnaround and low MOQ allow companies to rapidly test new formulations and get updated products into production quickly when facing time-sensitive reformulation requirements due to changing U.S. and international regulations.
Benefits include shorter supply chains for more responsive manufacturing, high standards of quality and compliance, fast turnaround rates, and serving as backup production when offshore sources falter.
Biotech and pharmaceutical manufacturing are expected to grow 6-8% annually through 2030, and Deloitte and The Manufacturing Institute project continued U.S. manufacturing job growth requiring millions of new workers this decade.
Softgel Source manufactures custom ingestible softgels for vitamin, medication, supplement, and pet product industries, focusing on prototype production and low-to-moderate volume manufacturing.
You can visit their website at https://softgelsource.com for more information about their services and capabilities.
Curated from 24-7 Press Release
